Home / Healthcare / Pre-Eclampsia Global Clinical Trials Review, H1, 2016

Pre-Eclampsia Global Clinical Trials Review, H1, 2016

Published: Apr 2016 | No Of Pages: 129 | Published By: GlobalData

Pre-Eclampsia Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, "Pre-Eclampsia Global Clinical Trials Review, H1, 2016" provides an overview of Pre-Eclampsia clinical trials scenario. This report provides top line data relating to the clinical trials on Pre-Eclampsia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData?s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Five Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Pre-Eclampsia to Cardiovascular Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Pre-Eclampsia to Cardiovascular Clinical Trials 17
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Pre-Eclampsia Therapeutics Clinical Trials 28
Prominent Drugs 30
Latest Clinical Trials News on Pre-Eclampsia 31
Jan 14, 2016: St. John Hospital Enrolling Patients in Phase 3 Trial for Early Onset Preeclampsia 31
Clinical Trial Profile Snapshots 32
Appendix 126
Abbreviations 126
Definitions 126
Research Methodology 127
Secondary Research 127
About GlobalData 128
Contact Us 128
Disclaimer 128
Source 129

Pre-Eclampsia Therapeutics, Global, Clinical Trials by Region, 2016* 6
Pre-Eclampsia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Pre-Eclampsia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Pre-Eclampsia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Pre-Eclampsia Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Pre-Eclampsia Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Pre-Eclampsia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12
Pre-Eclampsia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 13
Proportion of Pre-Eclampsia to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 14
Pre-Eclampsia Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Pre-Eclampsia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Pre-Eclampsia to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 18
Pre-Eclampsia Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19
Pre-Eclampsia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20
Pre-Eclampsia Therapeutics, Global, Clinical Trials by Phase, 2016* 21
Pre-Eclampsia Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22
Pre-Eclampsia Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23
Pre-Eclampsia Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24
Pre-Eclampsia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25
Pre-Eclampsia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 26
Pre-Eclampsia Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27
Pre-Eclampsia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29
Pre-Eclampsia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30

Pre-Eclampsia Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Pre-Eclampsia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Pre-Eclampsia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Pre-Eclampsia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
Pre-Eclampsia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Pre-Eclampsia Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Pre-Eclampsia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12
Pre-Eclampsia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 13
Proportion of Pre-Eclampsia to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 14
Pre-Eclampsia Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Pre-Eclampsia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Pre-Eclampsia to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 17
Pre-Eclampsia Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19
Pre-Eclampsia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20
Pre-Eclampsia Therapeutics, Global, Clinical Trials by Phase (%), 2016* 21
Pre-Eclampsia Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 22
Pre-Eclampsia Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23
Pre-Eclampsia Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24
Pre-Eclampsia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25
Pre-Eclampsia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 26
Pre-Eclampsia Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27
Pre-Eclampsia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
Pre-Eclampsia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30
GlobalData Methodology 127

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +